| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0005 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.001 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |